Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

AGENUS INC Director's Dealing 2016

Mar 8, 2016

34023_dirs_2016-03-08_4e4aaff6-98d0-4dfb-959f-6fe3af07a2a2.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AGENUS INC (AGEN)
CIK: 0001098972
Period of Report: 2016-03-07

Reporting Person: ARMEN GARO H (Chairman & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2016-03-07 Common Stock P 200000 $4.028 Acquired 1251228 Direct

Footnotes

F1: Dr. Armen's purchase of Agenus Inc. common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934, with Dr. Armen's sale of an equivalent number of shares of Agenus common stock at a weighted average price of $4.5919 per share on December 28 and December 29, 2015. Dr. Armen has paid to Agenus, as of March 8, 2016, $96,035.81, representing the full amount of the profit realized in connection with the short-swing transaction.